Inovio Pharmaceuticals got accelerated approval from the Food and Drug Administration for its drug Voceryq. Shares nearly quadrupled to $2.21 in after-hours trading. Intel shed another $1.5% to $64.77 ...
Semiconductor shares broadly fell following disappointing results and a downbeat outlook from Intel, along with an earnings miss from Amazon, which fueled fresh concerns around the artificial ...
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results